323 related articles for article (PubMed ID: 18991792)
1. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause.
Serock MR; Wells AK; Khalil RA
Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):165-86. PubMed ID: 18991792
[TBL] [Abstract][Full Text] [Related]
2. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
Khalil RA
Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
[TBL] [Abstract][Full Text] [Related]
3. Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.
do Nascimento GR; Barros YV; Wells AK; Khalil RA
Curr Hypertens Rev; 2009 Nov; 5(4):283-306. PubMed ID: 20694192
[TBL] [Abstract][Full Text] [Related]
4. Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.
Khalil RA
Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):29-46. PubMed ID: 20210774
[TBL] [Abstract][Full Text] [Related]
5. Vascular effects of estrogenic menopausal hormone therapy.
Reslan OM; Khalil RA
Rev Recent Clin Trials; 2012 Feb; 7(1):47-70. PubMed ID: 21864249
[TBL] [Abstract][Full Text] [Related]
6. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
7. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
Masood DE; Roach EC; Beauregard KG; Khalil RA
Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.
Smiley DA; Khalil RA
Curr Med Chem; 2009; 16(15):1863-87. PubMed ID: 19442151
[TBL] [Abstract][Full Text] [Related]
9. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.
Ross RL; Serock MR; Khalil RA
Curr Cardiol Rev; 2008 Nov; 4(4):309-22. PubMed ID: 20066139
[TBL] [Abstract][Full Text] [Related]
10. Sex steroids and vascular responses in hypertension and aging.
Qiao X; McConnell KR; Khalil RA
Gend Med; 2008; 5 Suppl A():S46-64. PubMed ID: 18395683
[TBL] [Abstract][Full Text] [Related]
11. Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.
Gencel VB; Benjamin MM; Bahou SN; Khalil RA
Mini Rev Med Chem; 2012 Feb; 12(2):149-74. PubMed ID: 22070687
[TBL] [Abstract][Full Text] [Related]
12. The cardiovascular effects of selective estrogen receptor modulators.
Christodoulakos GE; Lambrinoudaki IV; Botsis DC
Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
[TBL] [Abstract][Full Text] [Related]
13. Estrogens and Coronary Artery Disease: New Clinical Perspectives.
Meyer MR; Barton M
Adv Pharmacol; 2016; 77():307-60. PubMed ID: 27451102
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
15. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
16. Estrogen, selective estrogen receptor modulators and now mechanism-specific ligands of the estrogen or androgen receptor?
Khosla S
Trends Pharmacol Sci; 2003 Jun; 24(6):261-3. PubMed ID: 12823947
[TBL] [Abstract][Full Text] [Related]
17. Selective estrogen modulators in menopause.
Gambacciani M
Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
[TBL] [Abstract][Full Text] [Related]
18. An update on menopausal hormone replacement therapy in women and cardiovascular disease.
Valdiviezo C; Lawson S; Ouyang P
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):148-55. PubMed ID: 23422240
[TBL] [Abstract][Full Text] [Related]
19. Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery.
Patkar S; Farr TD; Cooper E; Dowell FJ; Carswell HV
Neurosci Res; 2011 Sep; 71(1):78-84. PubMed ID: 21624404
[TBL] [Abstract][Full Text] [Related]
20. Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease.
Khalil RA
Future Cardiol; 2007 May; 3(3):283-300. PubMed ID: 19804220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
